Health Top Stories

Hydroxychloroquine a drug that shares the world, Health News, ET HealthWorld

PARIS: Banned in some countries, promoted in others – the drug hydroxychloroquine as one potential treatment for the new coronavirus shares worldview. Researchers searching for approved drugs that could be reused as COVID-19 treatment had started testing hydroxychloroquine, usually used for treatment arthritisand chloroquine, an anti-malaria. Both drugs can cause potentially serious side effects, especially …

Hydroxychloroquine a drug that shares the world, Health News, ET HealthWorld Read More »

India’s drug regulator grants Gilead Sciences marketing authorization for remdesivir, Health News, ET HealthWorld

By Payal Banerjee New Delhi: India drug regulator have you given us pharma huge Gilead Sciences marketing authorization for its antiviral drug strap desivir for “limited emergency use“in hospitalized COVID-19 patients, given the pandemic crisis. The remediation approval process was accelerated given the emergency and unmet need for medication in light of coronavirus outbreak, a …

India’s drug regulator grants Gilead Sciences marketing authorization for remdesivir, Health News, ET HealthWorld Read More »

Need for unique and universal identification of protective health products during the Covid crisis, Health News, ET HealthWorld

by S SwaminathanCOO, GS1 India Demand for health protection equipment and products such as masks, gloves, PPE kits, cleansers, test kits, etc., has been intensified. This has led many new manufacturers to jump into producing protective products. As a result, we have the spread of these products on the market with little information to enable …

Need for unique and universal identification of protective health products during the Covid crisis, Health News, ET HealthWorld Read More »

ICMR Study, Health News, ET HealthWorld

NEW DELHI: At least 28% of 40,184 people who tested positive for Covid-19 between January 22 and April 30 in India was asymptomatic, a study conducted by the Indian Council for Medical Research (ICMR), which highlights that a large proportion of the tested and found positive were family contacts that did not exhibit symptoms. Asymptomatic …

ICMR Study, Health News, ET HealthWorld Read More »

Recovery rate is record high, 11,264 cured in 24 hours, Health News, ET HealthWorld

NEW DELHI: The number of enable Covid-19 cases fell marginally Saturday compared to the previous day due to a large number of recovered patients, even as the country recorded a record one-day increase of 265 deaths and 7,964 new cases. On Saturday, the Department of Health reported 86,422 active Covid-19 cases or patients currently undergoing …

Recovery rate is record high, 11,264 cured in 24 hours, Health News, ET HealthWorld Read More »

US FDA Requests 5 Companies To Remember Diabetes Medications With High Levels Of Probable Carcinogens, Health News, ET HealthWorld

NEW DELHI: The U.S. Food and Drug Administration (FDA) said on Thursday that it has recommended five pharmaceutical companies to voluntarily recall their metropine for diabetes medicine after the agency found high levels of a possible carcinogenic impurity in some versions of the drug. The agency said the drugs contained the likely carcinogenic N-nitrosodimethylamine (NDMA) …

US FDA Requests 5 Companies To Remember Diabetes Medications With High Levels Of Probable Carcinogens, Health News, ET HealthWorld Read More »

Sun Pharma gets DCGI approval for clinical trial of Nafamostat in Covid-19 patients, Health News, ET HealthWorld

MUMBAI: Sun Pharmaceutical Industries said on Friday it has received approval from the drug control general in India (DCGI) to initiate clinical trial with Nafamostat Mesilate i Covid-19 patients. Nafamostat is approved in Japan for ameliorating acute symptoms of pancreatitis and treating disseminated intravascular coagulation (DIC). Coronavirus lockdown: Latest updates A group of researchers from …

Sun Pharma gets DCGI approval for clinical trial of Nafamostat in Covid-19 patients, Health News, ET HealthWorld Read More »

Moderna extends lipid agreement to increase COVID-19 vaccine production, Health News, ET HealthWorld

Modern Inc. has extended an agreement to secure large quantities of lipids used to make its experimental COVID-19 vaccine in an effort to meet the rising demand for medicine, U.S. said the biotech company on Thursday. Moderna said last week that the vaccine candidate, the first to be tested in the United States, produced protective …

Moderna extends lipid agreement to increase COVID-19 vaccine production, Health News, ET HealthWorld Read More »